Panel - Envisioning the Role of GenAI in Modern Pharmacometric Workflows

Monday, October 20, 2025

3:00 PM - 3:30 PM MDT

Location: Willow Lake 3 - 5

Panelist(s)

Birgit Schoeberl, PhD (she/her/hers)

VP, Head of Data42
Novartis Institutes for BioMedical Research
Cambridge, Massachusetts, United States
Emily Nieves (she/her/hers)

Co-founder/ CEO
Delineate Inc., United States
Joshua F. Apgar, PhD (he/him/his)

VP QSP Sortware
Certara, Massachusetts, United States
Allison Claas, PhD (she/her/hers)

Associate Director
Novartis
Cambridge, Massachusetts, United States

Disclosure(s):

Birgit Schoeberl, PhD: No relevant disclosure to display

Emily Nieves: No financial relationships to disclose

Joshua F. Apgar, PhD: No financial relationships to disclose

Panel Discussion